Groundbreaking Malaria Vaccine under Test
Why in news?
- The World Health Organisation welcomed a pilot project in Malawi of administering a malaria vaccine to children below the age of 2 years. A total 3,60,000 children across three African countries — Malawi, Ghana and Kenya — will be covered every year with the vaccine.
What is the RTS, S (Mosquirix) vaccine?
- RTS, S/AS01 (trade name Mosquirix) is a recombinant protein-based malaria vaccine.
- A pilot project for vaccination has been launched on April 23, 2019 in Malawi. Ghana and Kenya are to join the program later this year.
- The vaccine has been developed by GSK (GlaxoSmithKline ) ....
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 Passport vs Citizenship: Legal Position Explained
- 2 FemTech in India: Transforming Women's Healthcare Through Digital Innovation
- 3 Right to Trauma Care: Transforming Emergency Healthcare in India
- 4 BRICS Indore Declaration: A Roadmap for Sustainable Agriculture and Food Security
- 5 Rising Urban Fire Disasters: A Growing Crisis amid Climate Change and Urbanisation
- 6 PCPNDT Act and the Challenge of Gender Imbalance: Supreme Court’s Observations
- 7 Solar-Integrated Transport Infrastructure: Transforming Mobility into Renewable Energy Networks
- 8 Drone Warfare: Evolving Dynamics of Modern Conflicts
- 9 Twin Climate and Energy Crises: UN Calls for Urgent Global Action
- 10 Hydropower Development in the Himalayas: Balancing Development and Ecological Sustainability
